Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study

BACKGROUND: Causative treatment of patients with wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is lacking. Recent reports indicate the potential use of epigallocatechin-3-gallate (EGCG), the most abundant catechin in green tea, to inhibit amyloid fibril formation. We sought to investiga...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drug Des Devel Ther
Asıl Yazarlar: Siepen, Fabian aus dem, Bauer, Ralf, Aurich, Matthias, Buss, Sebastian J, Steen, Henning, Altland, Klaus, Katus, Hugo A, Kristen, Arnt V
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4675646/
https://ncbi.nlm.nih.gov/pubmed/26673202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S96893
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller